Story perspectives

FDA Lifts Warning on Hormone Therapy, Women's Caucus Cheers

1/16/2026

38 8

Summary

Story summary

HHS Secretary Robert F. Kennedy Jr. and the Food and Drug Administration (FDA) lifted the black box warning on estrogen-based hormone replacement therapy.
House Democratic Women's Caucus praised the decision, saying it would benefit millions of women.
The caucus urged continued research on safety and effectiveness.
The caucus pressed the FDA to expand menopause research and education.
They warned that reducing funding for women's health research could reverse progress.

1 of 1

Story summary

HHS Secretary Robert F. Kennedy Jr. and the Food and Drug Administration (FDA) lifted the black box warning on estrogen-based hormone replacement therapy.
House Democratic Women's Caucus praised the decision, saying it would benefit millions of women.
The caucus urged continued research on safety and effectiveness.
The caucus pressed the FDA to expand menopause research and education.
They warned that reducing funding for women's health research could reverse progress.